Abstract
The clinical and biochemical correlations with joint damage progression over two years in a consecutive group of 68 patients with rheumatoid arthritis with disease duration of less than two years are reported. Joint damage was assessed with Larsen's severity scale and a measure of change in progression rate constructed. Initial haemoglobin concentration, Ritchie index, and Waaler-Rose titre in combination accounted for one third of the variance in joint damage progression. Rheumatoid factor (RF) concentrations were followed with enzyme linked immunosorbent assays (ELISAs) for IgG RF, IgA RF, and IgM RF. The RF concentrations, except IgG RF, decreased with time; significant correlations between RFs and disease activity were few and barely clinically useful. After two years IgG RF correlated significantly with a radiological score if early non-erosive changes were omitted. All RFs tended to correlate better with this radiological score at all three observation points. Analyses Backward stepwise multiple regression was performed using a radiological outcome measure as dependent variable and the clinical and laboratory measures as independent variables. Variables contributing with F <4 0 were excluded from the regression. The validity of the regressions was assessed by residual analyses. Regression analyses were performed for the different observation points separately. A combination of the initial values of the Ritchie index, haemoglobin concentration, and RF explained 32% of the variance in the absolute change of the joint damage index between the start of the study and two years. Age was a confounding factor and was corrected for. Table  4 shows the result of the analysis. The highest correlation obtained for a single variable (haemoglobin) was 0 30 and the combination of variables increased this to 0-57. Twenty five per cent of the variance in the change of the radiological progression rate could be explained by a set of variables-morning stiffness, active joint count, and IgG RF-obtained after 12 months (table 5) . It is noteworthy that the correlation with IgG RF was negative. The regression analysis increased the correlation from 0 30 (IgG RF) to 0-46.
Discussion
The early symptomatic phase of rheumatoid arthritis has attracted increasing attention in several recent studies in the hopes of defining better prognostic variables' 1-13 or gaining therapeutic advantages. 14 Our study aimed at applying sensitive immunochemical assays for RFs and correlating the results with clinical and radiological features.
Some of the patients in this study had been treated with different slow acting antirheumatic drugs, which might have influenced the RF concentrations. The study design did not allow measurement of possible effects.
One third of the variance in the progression of joint damage over two years could be explained by some of the clinical and laboratory variables obtained at the start of the study. The contributing variables were Ritchie index, haemoglobin concentration, and Waaler-Rose titre. Thus the conventional agglutination test was a more useful indicator of progression rate, though the regression coefficient for the Waaler-Rose test was barely significant.
In analyses of associations between serial changes in RFs and measures of disease activity only a few significant correlations during the first year were obtained, which were of little clinical relevance. This is in accordance with Scott et al, who found no advantage from serial measurements of IgM RFs and IgG RFs in assessing disease activity in patients during 12 months' treatment with gold or penicillamine. 
